(4-((1-benzyl-1H-benzo[d]imidazol-2-yl)methyl)piperazin-1-yl)(cyclopropyl)methanone

ID: ALA4871148

PubChem CID: 44064133

Max Phase: Preclinical

Molecular Formula: C23H26N4O

Molecular Weight: 374.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(C1CC1)N1CCN(Cc2nc3ccccc3n2Cc2ccccc2)CC1

Standard InChI:  InChI=1S/C23H26N4O/c28-23(19-10-11-19)26-14-12-25(13-15-26)17-22-24-20-8-4-5-9-21(20)27(22)16-18-6-2-1-3-7-18/h1-9,19H,10-17H2

Standard InChI Key:  XCWSXUSSVKWSNQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   19.9692   -5.2832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9679   -6.1106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6828   -6.5235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6810   -4.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3963   -5.2796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4012   -6.1060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1886   -6.3569    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6706   -5.6853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1809   -5.0196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4312   -4.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8756   -3.6238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4956   -5.6805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9038   -4.9636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7331   -4.9652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1412   -4.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7281   -3.5380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9021   -3.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4894   -4.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1391   -2.8227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9640   -2.8210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7251   -2.1091    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6777   -3.2307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6760   -2.4057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1288   -2.8406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5739   -2.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7670   -2.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5179   -3.1980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0745   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 22 20  1  0
 23 22  1  0
 20 23  1  0
 11 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 11  1  0
M  END

Associated Targets(Human)

ALDH1A1 Tchem Aldehyde dehydrogenase 1A1 (77053 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.49Molecular Weight (Monoisotopic): 374.2107AlogP: 3.14#Rotatable Bonds: 5
Polar Surface Area: 41.37Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.34CX LogP: 3.08CX LogD: 3.07
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -1.78

References

1. Ma Z, Jiang L, Li B, Liang D, Feng Y, Liu L, Jiang C..  (2021)  Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.,  46  [PMID:34403955] [10.1016/j.bmc.2021.116352]

Source